THZ1 has limited clinical utility due to poor metabolic stability, susceptibility to ABC transporter‐mediated efflux, and restricted blood‐brain barrier (BBB) penetration; however, it remains a valuable tool for elucidating CDK7‐dependent transcriptional vulnerabilities in GBM.5 Here, CDK7 is linked to glioblastoma.